By Charles Bankhead, Staff Writer, MedPage Today
Published: February 27, 2009
Reviewed by Dori F. Zaleznik, MD; Associate Clinical Professor of Medicine, Harvard Medical School, Boston.
ORLANDO, Feb. 27 -- Prostate cancer mortality risk declined by 50% in men taking statins for reasons unrelated to cancer, data from a case-control study showed.
The mortality benefit increased to almost two-thirds after adjustment for potential confounding factors, according to Stephen Marcella, M.D., of the University of Medicine and Dentistry of New Jersey School of Public Health in Piscataway. He reported his findings at the Genitourinary Cancers Symposium here./.../
No comments:
Post a Comment